Compared with the model using three different genes (PPARG, MDM2, and NANOG), which we reported in 2015 [9], the current molecular model not only accurately predicts the OS of patients with ESCC but also predicts the DFS and sensitivity to chemoradiation. Here, MDM2 is linked to esophageal squamous cell carcinoma.